Ferlay, J. et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int. J. Cancer 144, 1941–1953 (2019).
Article CAS PubMed Google Scholar
Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).
Johnson, D. E. et al. Head and neck squamous cell carcinoma. Nat. Rev. Dis. Prim. 6, 92 (2020).
HHS.gov. Smoking Cessation: A Report of the Surgeon General — Key Findings https://www.hhs.gov/surgeongeneral/reports-and-publications/tobacco/2020-cessation-sgr-factsheet-key-findings/index.html#:~:Text=2020%20Surgeon%20General’s%20Report%20Findings,a%20decade%20to%20life%20expectancy (2020).
Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424 (2018).
Chaturvedi, A. K. et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J. Clin. Oncol. 29, 4294–4301 (2011).
Article PubMed PubMed Central Google Scholar
Powell, S. F., Vu, L., Spanos, W. C. & Pyeon, D. The key differences between human papillomavirus-positive and -negative head and neck cancers: biological and clinical implications. Cancers 13, 5206 (2021).
Article CAS PubMed PubMed Central Google Scholar
Ferris, R. L. et al. Nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: efficacy and safety in CheckMate 141 by prior cetuximab use. Clin. Cancer Res. 25, 5221–5230 (2019).
Article CAS PubMed PubMed Central Google Scholar
Bonner, J. A. et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 354, 567–578 (2006).
Article CAS PubMed Google Scholar
Cramer, J. D., Burtness, B. & Ferris, R. L. Immunotherapy for head and neck cancer: recent advances and future directions. Oral. Oncol. 99, 104460 (2019).
Article CAS PubMed PubMed Central Google Scholar
Li, L. et al. Comprehensive immunogenomic landscape analysis of prognosis-related genes in head and neck cancer. Sci. Rep. 10, 6395 (2020).
Article CAS PubMed PubMed Central Google Scholar
Mito, I. et al. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma. Sci. Rep. 11, 16134 (2021).
Article CAS PubMed PubMed Central Google Scholar
Mandal, R. et al. The head and neck cancer immune landscape and its immunotherapeutic implications. JCI Insight 1, e89829 (2016).
Article PubMed PubMed Central Google Scholar
Jiang, A.-M. et al. Tumor mutation burden, immune cell infiltration, and construction of immune-related genes prognostic model in head and neck cancer. Int. J. Med. Sci. 18, 226–238 (2021).
Article CAS PubMed PubMed Central Google Scholar
Chen, X. et al. Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis. Mol. Immunol. 96, 28–36 (2018).
Article CAS PubMed Google Scholar
Petitprez, F. et al. B cells are associated with survival and immunotherapy response in sarcoma. Nature 577, 556–560 (2020).
Article CAS PubMed Google Scholar
Ruffin, A. T. et al. B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma. Nat. Commun. 12, 3349 (2021).
Article CAS PubMed PubMed Central Google Scholar
Wood, O. et al. Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors. Oncotarget 7, 56781–56797 (2016).
Article PubMed PubMed Central Google Scholar
Wuerdemann, N. et al. LAG-3, TIM-3 and VISTA expression on tumor-infiltrating lymphocytes in oropharyngeal squamous cell carcinoma-potential biomarkers for targeted therapy concepts. Int. J. Mol. Sci. 22, 379 (2020).
Article PubMed PubMed Central Google Scholar
Lechner, A. et al. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma. Oncotarget 8, 44418–44433 (2017).
Article PubMed PubMed Central Google Scholar
Liu, Z. et al. Novel effector phenotype of Tim-3+ regulatory T cells leads to enhanced suppressive function in head and neck cancer patients. Clin. Cancer Res. 24, 4529–4538 (2018).
Article CAS PubMed PubMed Central Google Scholar
Liu, J.-F. et al. Blockade of TIM3 relieves immunosuppression through reducing regulatory T cells in head and neck cancer. J. Exp. Clin. Cancer Res. 37, 44 (2018).
Article PubMed PubMed Central Google Scholar
Duhen, T. et al. Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors. Nat. Commun. 9, 2724 (2018).
Article PubMed PubMed Central Google Scholar
Hwang, B., Lee, J. H. & Bang, D. Single-cell RNA sequencing technologies and bioinformatics pipelines. Exp. Mol. Med. 50, 1–14 (2018).
Article CAS PubMed PubMed Central Google Scholar
Kuksin, M. et al. Applications of single-cell and bulk RNA sequencing in onco-immunology. Eur. J. Cancer 149, 193–210 (2021).
Article CAS PubMed Google Scholar
Chaudhry, F. et al. Single-cell RNA sequencing of the cardiovascular system: new looks for old diseases. Front. Cardiovasc. Med. 6, 173 (2019).
Article CAS PubMed PubMed Central Google Scholar
Li, X. & Wang, C.-Y. From bulk, single-cell to spatial RNA sequencing. Int. J. Oral. Sci. 13, 36 (2021).
Article PubMed PubMed Central Google Scholar
Kürten, C. H. L. et al. Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing. Nat. Commun. 12, 7338 (2021).
Article PubMed PubMed Central Google Scholar
Cillo, A. R. et al. Immune landscape of viral- and carcinogen-driven head and neck cancer. Immunity 52, 183–199.e9 (2020).
Article CAS PubMed PubMed Central Google Scholar
Puram, S. V. et al. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell 171, 1611–1624.e24 (2017).
Article CAS PubMed PubMed Central Google Scholar
Zhang, Q. et al. Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals distinct cancer-associated fibroblasts in head and neck squamous cell carcinoma. Ann. Transl. Med. 9, 1017 (2021).
Article CAS PubMed PubMed Central Google Scholar
Nordfors, C. et al. CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma. Eur. J. Cancer 49, 2522–2530 (2013).
Article CAS PubMed Google Scholar
Wuerdemann, N. et al. PD-L1 expression and a high tumor infiltrate of CD8+ lymphocytes predict outcome in patients with oropharyngeal squamous cells carcinoma. Int. J. Mol. Sci. 21, 5228 (2020).
Article CAS PubMed PubMed Central Google Scholar
Zhou, Z. et al. PD-L1 in combination with CD8+ TIL and HIF-1α are promising prognosis predictors of head and neck squamous cell carcinoma. Cancer Manag. Res. 12, 13233–13239 (2020).
Article CAS PubMed PubMed Central Google Scholar
Xiao, Y. et al. CD103+ T and dendritic cells indicate a favorable prognosis in oral cancer. J. Dent. Res. 98, 1480–1487 (2019).
Article CAS PubMed Google Scholar
McKinney, E. F. & Smith, K. G. T cell exhaustion and immune-mediated disease-the potential for therapeutic exhaustion. Curr. Opin. Immunol. 43, 74–80 (2016).
Article CAS PubMed Google Scholar
Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15, 486–499 (2015).
留言 (0)